Idra stock zacks

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Idera Pharmaceuticals, Inc. (IDRA) in Focus: Stock Stock ... Mar 31, 2014 · Idera Pharmaceuticals, Inc. (IDRA) in Focus: Stock Stock Surges 17.8%. Zacks Equity Research . Zacks. 31 March 2014. Reblog. Share. Tweet. Share.

Stock quote for Idera Pharmaceuticals, Inc. Common Stock Common Stock (IDRA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Idera Pharmaceuticals Stock Quote: IDRA Stock News, Quotes ... Nov 06, 2019 · IDRA, Idera Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Idera Pharmaceuticals, Inc. Common Stock (IDRA) Real-Time ... Mar 27, 2020 · IDRA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

Nov 04, 2019 · Idera Pharmaceuticals Inc. company facts, information and stock details by MarketWatch. View idra business summary and other industry information.

Stocks Analysis by Zacks Investment Research covering: Idera Pharmaceuticals Inc, ANI Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com. Breaking News. Idera Pharmaceuticals, Inc. (IDRA) Dividend Date &amp ... See the upcoming ex dividend date and dividend history for Idera Pharmaceuticals, Inc. (IDRA). Stay alerted to dividend announcements for IDRA and all the companies you follow at NASDAQ.com Idera Pharmaceuticals (NASDAQ:IDRA) Upgraded to “Buy” at ... Idera Pharmaceuticals (NASDAQ:IDRA) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, ValuEngine reports. Several other analysts have also weighed in on the stock. Zacks Investment Research lowered shares of Idera Pharmaceuticals from a “buy” rating to a […]

Idera Pharmaceuticals News | Markets Insider

ADAP Adaptimmune Therapeutics — Stock Price ... - StockTwits Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. IDRA Stock | Message Board | Idera Pharmaceuticals ... Dec 23, 2019 · IDRA Stock Message Board for Investors. Idera Pharmaceuticals Stock Price, News and Company Updates. Message Board Total Posts: 79 Stock News - TD Ameritrade Company profile. Idera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. Idera Pharmaceuticals, Inc. (IDRA) in Focus: Stock Stock ...

Historical daily share price chart and data for Idera Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Idera Pharmaceuticals as of March 13, 2020 is 1.18.. The all-time high Idera Pharmaceuticals stock closing price was 4361.60 on January 31, 1996.; The Idera Pharmaceuticals 52-week high stock price is 4.19, which is 255.1% above the current share price.

IDRA investment & stock information. Get the latest Idera Pharmaceuticals, Inc. IDRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D. Style  IDRA: Idera Pharmaceuticals, Inc. - Earnings Announcements. Stay up to date with lastest View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks Equity  Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. 18 May 2018 Investors in Idera Pharmaceuticals (IDRA) need to pay close attention to the stock based on moves in the options market lately. 10 May 2019 The stock has moved higher by 25% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance 

Find the latest Idera Pharmaceuticals, Inc. (IDRA) stock quote, history, news and other vital information to help you with your stock trading Zacks•last month 

View Idera Pharmaceuticals, Inc. IDRA investment & stock information. Get the latest Idera Pharmaceuticals, Inc. IDRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Idera Pharmaceuticals (IDRA) Stock Price History | wallmine Dec 24, 2018 · Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.